Cargando…
Clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (APBI) using multi-lumen/catheter applicators
PURPOSE: Accelerated partial breast irradiation (APBI) using a single-lumen device is associated with better cosmetic outcomes if the spacing between the applicator and skin is > 7 mm. However, there are no reports addressing the late toxicity and clinical outcomes in patients treated with single...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241383/ https://www.ncbi.nlm.nih.gov/pubmed/28115955 http://dx.doi.org/10.5114/jcb.2016.64830 |
_version_ | 1782496177999052800 |
---|---|
author | Akhtari, Mani Abboud, Mirna Szeja, Sean Pino, Ramiro Lewis, Gary D. Bass, Barbara L. Miltenburg, Darlene M. Butler, E. Brian Teh, Bin S. |
author_facet | Akhtari, Mani Abboud, Mirna Szeja, Sean Pino, Ramiro Lewis, Gary D. Bass, Barbara L. Miltenburg, Darlene M. Butler, E. Brian Teh, Bin S. |
author_sort | Akhtari, Mani |
collection | PubMed |
description | PURPOSE: Accelerated partial breast irradiation (APBI) using a single-lumen device is associated with better cosmetic outcomes if the spacing between the applicator and skin is > 7 mm. However, there are no reports addressing the late toxicity and clinical outcomes in patients treated with single-entry multi-lumen/catheter applicators who had close skin spacing (7 mm or less). We undertook this study to report clinical outcome, acute and late toxicity as well as cosmesis of early stage breast cancer patients with close skin spacing treated with APBI using multi-lumen or multi-catheter devices. MATERIAL AND METHODS: This is a retrospective study of all breast cancer patients who had undergone APBI using single-entry multi-lumen/catheter devices in a single institution between 2008 to 2012. The study was limited to those with ≤ 7 mm spacing between the device and skin. RESULTS: We identified 37 patients and 38 lesions with skin spacing of ≤ 7 mm. Seven lesions (18%) had spacing of ≤ 3 mm. Median follow-up was 47.5 months. There was one case of ipsilateral breast recurrence and one ipsilateral axillary recurrence. Based on RTOG criteria, 22 treated lesions experienced grade 1 and 9 lesions experienced grade 2 toxicity. Twenty-one lesions experienced late grade 1 toxicity. One patient had to undergo mastectomy due to mastitis. Twenty-four treated breasts showed excellent and 11 had good cosmetic outcome. Overall cosmesis trended towards a significant correlation with skin spacing. However, all patients with ≤ 3 mm skin spacing experienced acute and late toxicities. CONCLUSIONS: Accelerated partial breast irradiation can be safely performed in patients with skin spacing of ≤ 7 mm using single-entry multi-lumen/catheter applicators with excellent cosmetic outcomes and an acceptable toxicity profile. However, skin spacing of ≤ 3 mm is associated with acute and late toxicity and should be avoided if possible. |
format | Online Article Text |
id | pubmed-5241383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-52413832017-01-23 Clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (APBI) using multi-lumen/catheter applicators Akhtari, Mani Abboud, Mirna Szeja, Sean Pino, Ramiro Lewis, Gary D. Bass, Barbara L. Miltenburg, Darlene M. Butler, E. Brian Teh, Bin S. J Contemp Brachytherapy Original Paper PURPOSE: Accelerated partial breast irradiation (APBI) using a single-lumen device is associated with better cosmetic outcomes if the spacing between the applicator and skin is > 7 mm. However, there are no reports addressing the late toxicity and clinical outcomes in patients treated with single-entry multi-lumen/catheter applicators who had close skin spacing (7 mm or less). We undertook this study to report clinical outcome, acute and late toxicity as well as cosmesis of early stage breast cancer patients with close skin spacing treated with APBI using multi-lumen or multi-catheter devices. MATERIAL AND METHODS: This is a retrospective study of all breast cancer patients who had undergone APBI using single-entry multi-lumen/catheter devices in a single institution between 2008 to 2012. The study was limited to those with ≤ 7 mm spacing between the device and skin. RESULTS: We identified 37 patients and 38 lesions with skin spacing of ≤ 7 mm. Seven lesions (18%) had spacing of ≤ 3 mm. Median follow-up was 47.5 months. There was one case of ipsilateral breast recurrence and one ipsilateral axillary recurrence. Based on RTOG criteria, 22 treated lesions experienced grade 1 and 9 lesions experienced grade 2 toxicity. Twenty-one lesions experienced late grade 1 toxicity. One patient had to undergo mastectomy due to mastitis. Twenty-four treated breasts showed excellent and 11 had good cosmetic outcome. Overall cosmesis trended towards a significant correlation with skin spacing. However, all patients with ≤ 3 mm skin spacing experienced acute and late toxicities. CONCLUSIONS: Accelerated partial breast irradiation can be safely performed in patients with skin spacing of ≤ 7 mm using single-entry multi-lumen/catheter applicators with excellent cosmetic outcomes and an acceptable toxicity profile. However, skin spacing of ≤ 3 mm is associated with acute and late toxicity and should be avoided if possible. Termedia Publishing House 2016-12-29 2016-12 /pmc/articles/PMC5241383/ /pubmed/28115955 http://dx.doi.org/10.5114/jcb.2016.64830 Text en Copyright: © 2016 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Original Paper Akhtari, Mani Abboud, Mirna Szeja, Sean Pino, Ramiro Lewis, Gary D. Bass, Barbara L. Miltenburg, Darlene M. Butler, E. Brian Teh, Bin S. Clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (APBI) using multi-lumen/catheter applicators |
title | Clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (APBI) using multi-lumen/catheter applicators |
title_full | Clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (APBI) using multi-lumen/catheter applicators |
title_fullStr | Clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (APBI) using multi-lumen/catheter applicators |
title_full_unstemmed | Clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (APBI) using multi-lumen/catheter applicators |
title_short | Clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (APBI) using multi-lumen/catheter applicators |
title_sort | clinical outcomes, toxicity, and cosmesis in breast cancer patients with close skin spacing treated with accelerated partial breast irradiation (apbi) using multi-lumen/catheter applicators |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241383/ https://www.ncbi.nlm.nih.gov/pubmed/28115955 http://dx.doi.org/10.5114/jcb.2016.64830 |
work_keys_str_mv | AT akhtarimani clinicaloutcomestoxicityandcosmesisinbreastcancerpatientswithcloseskinspacingtreatedwithacceleratedpartialbreastirradiationapbiusingmultilumencatheterapplicators AT abboudmirna clinicaloutcomestoxicityandcosmesisinbreastcancerpatientswithcloseskinspacingtreatedwithacceleratedpartialbreastirradiationapbiusingmultilumencatheterapplicators AT szejasean clinicaloutcomestoxicityandcosmesisinbreastcancerpatientswithcloseskinspacingtreatedwithacceleratedpartialbreastirradiationapbiusingmultilumencatheterapplicators AT pinoramiro clinicaloutcomestoxicityandcosmesisinbreastcancerpatientswithcloseskinspacingtreatedwithacceleratedpartialbreastirradiationapbiusingmultilumencatheterapplicators AT lewisgaryd clinicaloutcomestoxicityandcosmesisinbreastcancerpatientswithcloseskinspacingtreatedwithacceleratedpartialbreastirradiationapbiusingmultilumencatheterapplicators AT bassbarbaral clinicaloutcomestoxicityandcosmesisinbreastcancerpatientswithcloseskinspacingtreatedwithacceleratedpartialbreastirradiationapbiusingmultilumencatheterapplicators AT miltenburgdarlenem clinicaloutcomestoxicityandcosmesisinbreastcancerpatientswithcloseskinspacingtreatedwithacceleratedpartialbreastirradiationapbiusingmultilumencatheterapplicators AT butlerebrian clinicaloutcomestoxicityandcosmesisinbreastcancerpatientswithcloseskinspacingtreatedwithacceleratedpartialbreastirradiationapbiusingmultilumencatheterapplicators AT tehbins clinicaloutcomestoxicityandcosmesisinbreastcancerpatientswithcloseskinspacingtreatedwithacceleratedpartialbreastirradiationapbiusingmultilumencatheterapplicators |